Evidence map›Paper›PMID 27006395›Full record

ArticleThe Journal of biological chemistry2016

Brain-derived Neurotrophic Factor in Megakaryocytes.

Pedro Chacón-Fernández, Katharina Säuberli, Maria Colzani, Thomas Moreau, Cedric Ghevaert, Yves-Alain Barde

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 109 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
109citing papers in PubMed, 2 pooled it
8.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

109 citing papers in PubMed, 2 syntheses or guidelines pooled it, 180 citations in OpenAlex.

  1. Pooled it
  2. Meta-Analysis of BDNF Levels in Autism.Cellular and molecular neurobiology · 2017
    Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Observational
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article

49 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Pedro Chacón-FernándezFrom the School of Biosciences, Cardiff University, Cardiff CF10 3AX, Wales and.
Katharina SäuberliFrom the School of Biosciences, Cardiff University, Cardiff CF10 3AX, Wales and.
Maria Colzanithe Department of Haematology, University of Cambridge, Cambridge CB2 0PT, United Kingdom.
Thomas Moreauthe Department of Haematology, University of Cambridge, Cambridge CB2 0PT, United Kingdom.
Cedric Ghevaertthe Department of Haematology, University of Cambridge, Cambridge CB2 0PT, United Kingdom.
Yves-Alain BardeFrom the School of Biosciences, Cardiff University, Cardiff CF10 3AX, Wales and bardey@cardiff.ac.uk.ORCID http://orcid.org/0000-0002-7627-461X
Cardiff University · GBUniversity of Cambridge · GB

Funding

British Heart Foundation FS/09/039/27788Department of Health RP-PG-0310-1002Medical Research Council MC_PC_12009Medical Research Council MR/L022982/1
6 · The paper itself

Abstract

The biosynthesis of endogenous brain-derived neurotrophic factor (BDNF) has thus far been examined in neurons where it is expressed at very low levels, in an activity-dependent fashion. In humans, BDNF has long been known to accumulate in circulating platelets, at levels far higher than in the brain. During the process of blood coagulation, BDNF is released from platelets, which has led to its extensive use as a readily accessible biomarker, under the assumption that serum levels may somehow reflect brain levels. To identify the cellular origin of BDNF in platelets, we established primary cultures of megakaryocytes, the progenitors of platelets, and we found that human and rat megakaryocytes express the BDNF gene. Surprisingly, the pattern of mRNA transcripts is similar to neurons. In the presence of thapsigargin and external calcium, the levels of the mRNA species leading to efficient BDNF translation rapidly increase. Under these conditions, pro-BDNF, the obligatory precursor of biologically active BDNF, becomes readily detectable. Megakaryocytes store BDNF in α-granules, with more than 80% of them also containing platelet factor 4. By contrast, BDNF is undetectable in mouse megakaryocytes, in line with the absence of BDNF in mouse serum. These findings suggest that alterations of BDNF levels in human serum as reported in studies dealing with depression or physical exercise may primarily reflect changes occurring in megakaryocytes and platelets, including the ability of the latter to retain and release BDNF.

Indexed as

AnimalsBlood CoagulationBlood PlateletsBrain-Derived Neurotrophic FactorCalciumChlorocebus aethiopsCOS CellsHumansMegakaryocytesMiceNeuronsRatsRats, WistarRNA, MessengerSecretory VesiclesSpecies SpecificityBrain-Derived Neurotrophic FactorCalciumRNA, MessengerThapsigarginbloodbrain-derived neurotrophic factor (BDNF)neurobiologyneurochemistryneurotrophin

Identifiers

PMID27006395
PMCPMC4858990
OpenAlexW2311144058

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.